Logo image of IDN

INTELLICHECK INC (IDN) Stock Fundamental Analysis

NASDAQ:IDN - Nasdaq - US45817G2012 - Common Stock - Currency: USD

2.65  +0.08 (+3.11%)

Fundamental Rating

4

Overall IDN gets a fundamental rating of 4 out of 10. We evaluated IDN against 285 industry peers in the Software industry. IDN has a great financial health rating, but its profitability evaluates not so good. IDN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year IDN has reported negative net income.
IDN had a negative operating cash flow in the past year.
In the past 5 years IDN always reported negative net income.
In the past 5 years IDN reported 4 times negative operating cash flow.
IDN Yearly Net Income VS EBIT VS OCF VS FCFIDN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M

1.2 Ratios

IDN has a Return On Assets of -4.39%. This is comparable to the rest of the industry: IDN outperforms 50.88% of its industry peers.
The Return On Equity of IDN (-5.17%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -4.39%
ROE -5.17%
ROIC N/A
ROA(3y)-9.95%
ROA(5y)-13.83%
ROE(3y)-12.48%
ROE(5y)-17.36%
ROIC(3y)N/A
ROIC(5y)N/A
IDN Yearly ROA, ROE, ROICIDN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40

1.3 Margins

The Gross Margin of IDN (90.84%) is better than 97.89% of its industry peers.
In the last couple of years the Gross Margin of IDN has remained more or less at the same level.
IDN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 90.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.95%
GM growth 5Y0.85%
IDN Yearly Profit, Operating, Gross MarginsIDN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

7

2. Health

2.1 Basic Checks

IDN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for IDN has been increased compared to 1 year ago.
Compared to 5 years ago, IDN has more shares outstanding
IDN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
IDN Yearly Shares OutstandingIDN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
IDN Yearly Total Debt VS Total AssetsIDN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

IDN has an Altman-Z score of 1.75. This is a bad value and indicates that IDN is not financially healthy and even has some risk of bankruptcy.
IDN has a Altman-Z score (1.75) which is in line with its industry peers.
There is no outstanding debt for IDN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.75
ROIC/WACCN/A
WACC11.08%
IDN Yearly LT Debt VS Equity VS FCFIDN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M

2.3 Liquidity

IDN has a Current Ratio of 3.11. This indicates that IDN is financially healthy and has no problem in meeting its short term obligations.
IDN has a better Current ratio (3.11) than 75.09% of its industry peers.
IDN has a Quick Ratio of 3.11. This indicates that IDN is financially healthy and has no problem in meeting its short term obligations.
IDN has a better Quick ratio (3.11) than 75.44% of its industry peers.
Industry RankSector Rank
Current Ratio 3.11
Quick Ratio 3.11
IDN Yearly Current Assets VS Current LiabilitesIDN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

6

3. Growth

3.1 Past

IDN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 50.00%, which is quite impressive.
Looking at the last year, IDN shows a small growth in Revenue. The Revenue has grown by 5.78% in the last year.
IDN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.16% yearly.
EPS 1Y (TTM)50%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
Revenue 1Y (TTM)5.78%
Revenue growth 3Y6.86%
Revenue growth 5Y21.16%
Sales Q2Q%14.7%

3.2 Future

The Earnings Per Share is expected to grow by 55.05% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 10.75% on average over the next years. This is quite good.
EPS Next Y46.13%
EPS Next 2Y55.05%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.48%
Revenue Next 2Y10.75%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
IDN Yearly Revenue VS EstimatesIDN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M 20M
IDN Yearly EPS VS EstimatesIDN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.1 -0.2 -0.3 -0.4 -0.5

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IDN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IDN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IDN Price Earnings VS Forward Price EarningsIDN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IDN Per share dataIDN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

IDN's earnings are expected to grow with 55.05% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y55.05%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for IDN!.
Industry RankSector Rank
Dividend Yield N/A

INTELLICHECK INC

NASDAQ:IDN (4/24/2025, 8:17:20 PM)

2.65

+0.08 (+3.11%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-20 2025-03-20/amc
Earnings (Next)05-07 2025-05-07
Inst Owners42.73%
Inst Owner Change0.03%
Ins Owners4.39%
Ins Owner Change-2.36%
Market Cap52.52M
Analysts72.5
Price Target3.32 (25.28%)
Short Float %0.89%
Short Ratio2.64
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)17.45%
Min EPS beat(2)-197.1%
Max EPS beat(2)232.01%
EPS beat(4)3
Avg EPS beat(4)33.27%
Min EPS beat(4)-197.1%
Max EPS beat(4)232.01%
EPS beat(8)5
Avg EPS beat(8)176.42%
EPS beat(12)9
Avg EPS beat(12)123.29%
EPS beat(16)9
Avg EPS beat(16)42.12%
Revenue beat(2)1
Avg Revenue beat(2)6.93%
Min Revenue beat(2)-2.53%
Max Revenue beat(2)16.39%
Revenue beat(4)2
Avg Revenue beat(4)3.19%
Min Revenue beat(4)-7.43%
Max Revenue beat(4)16.39%
Revenue beat(8)4
Avg Revenue beat(8)2.29%
Revenue beat(12)5
Avg Revenue beat(12)1.06%
Revenue beat(16)9
Avg Revenue beat(16)5.16%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-33.35%
EPS NQ rev (3m)-33.35%
EPS NY rev (1m)58.97%
EPS NY rev (3m)58.97%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)2.58%
Revenue NY rev (3m)2.58%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.63
P/FCF N/A
P/OCF N/A
P/B 2.96
P/tB 7.22
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)-0.14
OCFYN/A
SpS1.01
BVpS0.9
TBVpS0.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.39%
ROE -5.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 90.84%
FCFM N/A
ROA(3y)-9.95%
ROA(5y)-13.83%
ROE(3y)-12.48%
ROE(5y)-17.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.95%
GM growth 5Y0.85%
F-Score4
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 482.8%
Cap/Sales 10.53%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.11
Quick Ratio 3.11
Altman-Z 1.75
F-Score4
WACC11.08%
ROIC/WACCN/A
Cap/Depr(3y)241.87%
Cap/Depr(5y)271.66%
Cap/Sales(3y)4.79%
Cap/Sales(5y)4.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
EPS Next Y46.13%
EPS Next 2Y55.05%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.78%
Revenue growth 3Y6.86%
Revenue growth 5Y21.16%
Sales Q2Q%14.7%
Revenue Next Year11.48%
Revenue Next 2Y10.75%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y48.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year137.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-318.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-316.38%
OCF growth 3YN/A
OCF growth 5YN/A